Skip to main content

HCC 18: Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid

HCC 18, Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid, is one of the 115 payment categories in the CMS-HCC V28 model. 26 ICD-10-CM codes map to it in the payment year 2027 mapping, and a documented diagnosis in the category adds a relative factor of 2.341 to the risk score of a community, non-dual, aged beneficiary (2.486 disabled, 1.110 institutional). It is overridden when a more severe category in its hierarchy is present (HCC 17) and it in turn overrides HCC 19, HCC 20, HCC 21, HCC 22, HCC 23.

QuickIntell editorial content · Legacy registry date · Review not verified

Data effective
Data currency: ICD-10-CM to HCC mapping PY2027 initial (effective dates of service 2026, payment year 2027); CMS-HCC V28 model software V2826.115.T2 (effective payment year 2027). Next CMS release: PY2027 midyear final mapping (spring 2027) and PY2028 proposed model (February 2027).
Mapped ICD-10-CM codes
26
Factor, community non-dual aged
2.341
Factor, institutional
1.110
Hierarchy
Overridden by HCC 17
Disease group
Neoplasm

Relative factors by segment

Each segment is a separate regression; the factor is added to the beneficiary's demographic factors and other categories, then normalized and reduced by the coding intensity adjustment before it meets the plan's base rate. A factor of 1.000 equals the expected cost of an average beneficiary.

CMS-HCC V28 relative factors for HCC 18 by model segment
SegmentModel codeRelative factor
Community, non-dual, agedCNA_HCC182.341
Community, non-dual, disabledCND_HCC182.486
Community, full-benefit dual, agedCFA_HCC182.277
Community, full-benefit dual, disabledCFD_HCC182.537
Community, partial-benefit dual, agedCPA_HCC182.166
Community, partial-benefit dual, disabledCPD_HCC182.403
Long-term institutionalINS_HCC181.110

Hierarchy

Hierarchical condition categories pay only the most severe manifestation of a disease. When HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) is also documented for the same beneficiary, HCC 18 is dropped from the score. When HCC 18 is present it drops HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers), HCC 20 (Lung and Other Severe Cancers), HCC 21 (Lymphoma and Other Cancers), HCC 22 (Bladder, Colorectal, and Other Cancers), HCC 23 (Prostate, Breast, and Other Cancers and Tumors), so documenting the less severe condition alongside it adds nothing to payment but still matters for the clinical record.

ICD-10-CM codes that map to HCC 18

26 codes map to this category in the PY2027 initial mapping, concentrated in the C79 (14), C77 (5), C91 (3), C95 (3), C80 (1) code families. Descriptions are the CMS mapping descriptions for the FY2026 code set; a code that is deleted or split in the October code update stays valid for dates of service before the change.

ICD-10-CM codes mapped to HCC 18 in the CMS PY2027 initial mapping
ICD-10-CMDescription
C770Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
C772Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
C774Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes
C775Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes
C779Secondary and unspecified malignant neoplasm of lymph node, unspecified
C7910Secondary malignant neoplasm of unspecified urinary organs
C7911Secondary malignant neoplasm of bladder
C7919Secondary malignant neoplasm of other urinary organs
C792Secondary malignant neoplasm of skin
C7951Secondary malignant neoplasm of bone
C7952Secondary malignant neoplasm of bone marrow
C7960Secondary malignant neoplasm of unspecified ovary
C7961Secondary malignant neoplasm of right ovary
C7962Secondary malignant neoplasm of left ovary
C7963Secondary malignant neoplasm of bilateral ovaries
C7981Secondary malignant neoplasm of breast
C7982Secondary malignant neoplasm of genital organs
C7989Secondary malignant neoplasm of other specified sites
C799Secondary malignant neoplasm of unspecified site
C800Disseminated malignant neoplasm, unspecified
C9100Acute lymphoblastic leukemia not having achieved remission
C9101Acute lymphoblastic leukemia, in remission
C9102Acute lymphoblastic leukemia, in relapse
C9500Acute leukemia of unspecified cell type not having achieved remission
C9501Acute leukemia of unspecified cell type, in remission
C9502Acute leukemia of unspecified cell type, in relapse

Where these codes sat in the V22 model

The V28 recalibration renumbered and regrouped categories; this table shows which legacy V22 categories the same ICD-10 codes belonged to, which is the quickest way to reconcile a V22-era HCC gap list with the current model.

V22 categories that the HCC 18 codes mapped to
V22 HCCCodes
822
104

Capturing and defending the category

A category counts for a payment year when a mapped diagnosis is documented at least once during the data collection year by an acceptable provider type at a face-to-face or audio-video encounter, and when the note shows the condition was monitored, evaluated, assessed or treated. Chronic conditions do not carry forward: a category that is not re-documented in the year drops out of the score, which is why annual wellness visits and problem-list reconciliation are where most recapture happens. Risk adjustment data validation audits sample enrollees and ask for the medical record behind each submitted category; an unsupported category is removed and, under the extrapolation rules, the error rate is applied across the contract. The QuickIntell risk adjustment product surfaces suspected and unsupported categories from the chart, and the HCC hub lists every V28 category with its factor and code count.

Frequently asked questions

Which ICD-10 codes map to HCC 18?

26 ICD-10-CM codes map to HCC 18 in the CMS PY2027 initial mapping, for example C770 Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck; C772 Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes; C774 Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes; C775 Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes. The full list is on this page; a code counts only when it is documented at a face-to-face or video encounter in the data collection year and supported by the record.

How much does HCC 18 add to a risk score?

The V28 relative factor for HCC 18 is 2.341 for a community, non-dual, aged beneficiary, 2.277 for full-benefit dual aged, 2.486 for non-dual disabled and 1.110 for long-term institutional members. A factor of 1.000 equals the expected annual cost of an average beneficiary, so the category's share of the payment follows the plan's base rate for that segment.

Does HCC 18 count together with related categories?

No. Within a hierarchy only the most severe category is paid. HCC 18 is dropped when HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) is also present, and it drops HCC 19, HCC 20, HCC 21, HCC 22, HCC 23 when it is present.

What has to be documented for HCC 18 to be valid?

The diagnosis must be recorded by an acceptable provider type during a face-to-face or audio-video encounter in the service year, with the note showing that the condition was monitored, evaluated, assessed or treated. Risk adjustment data validation audits recover payment for categories the record does not support, so the code on the claim and the assessment in the note must match.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.

Disclaimer

Relative factors and mappings are reproduced from the CMS risk adjustment model files as an operational reference. Payment depends on the plan's base rate, normalization, the coding intensity adjustment and the enrollee's segment. Not legal, clinical or billing advice.